September 2020

home / publications / health-system-edition / september2020
Using Anticoagulants to Treat Patients With Obesity Presents Challenges

Using Anticoagulants to Treat Patients With Obesity Presents Challenges

Alana Hippensteele, Lead Editor
October 5th 2020
ArticleHealth-System Edition

Leaders in the field provide an overview of the DOAC drug class and how best to use the growing number of options.

Many Platforms Offer Rapid Detection in Bloodstream Infections

Many Platforms Offer Rapid Detection in Bloodstream Infections

Kathryn Lincoln, PharmD, BCPS, BCIDP;Ryan W. Stevens, PharmD, BCIDP;Joseph J. Carreno, PharmD, MPH
October 2nd 2020
ArticleHealth-System Edition

Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.

Plethora of Clinical Trials Explore Gastric Cancer Treatments

Plethora of Clinical Trials Explore Gastric Cancer Treatments

Jerry A. Barbee Jr, PharmD, BCPS, CPh;Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP;Taylor A. VandenBerg, PharmD candidate
October 1st 2020
ArticleHealth-System Edition

Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.

Anticoagulants, Antiretrovirals Can Prevent Strokes in AF for Patients With HIV

Anticoagulants, Antiretrovirals Can Prevent Strokes in AF for Patients With HIV

Gina Dube, PharmD, RPh, CACP
September 30th 2020
ArticleHealth-System Edition

Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.

Consider Real Costs Before Implementing a 340B Program

Consider Real Costs Before Implementing a 340B Program

Kenneth Maxik, MBA, MBB, FACHE;Craig Kimble, PharmD, MBA, MS, BCACP;Alberto Coustasse-Hencke, DrPH, MD, MBA, MPH
September 29th 2020
ArticleHealth-System Edition

Proposed CMS changes could hurt many health systems that are already struggling due to COVID-19 pandemic.

LTC Pharmacists Drive Positive Clinical Outcomes

LTC Pharmacists Drive Positive Clinical Outcomes

Russ Procopio, MBA, BS
September 28th 2020
ArticleHealth-System Edition

Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.

Patient Assistance Programs Are the Good, the Bad, and the Ugly

Patient Assistance Programs Are the Good, the Bad, and the Ugly

Curtis E. Haas, PharmD, FCCP
September 27th 2020
ArticleHealth-System Edition

Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.

Asembia offers a complete ecosystem of products and services focused on financial solutions and contracting programs to the specialty pharmacy market.

Asembia offers a complete ecosystem of products and services focused on financial solutions and contracting programs to the specialty pharmacy market.

September 27th 2020
ArticleHealth-System Edition

Asembia is the industry’s leading group purchasing organization (GPO) focused on the specialty pharmacy market.

When Will a Vaccine Be Ready?

When Will a Vaccine Be Ready?

Mike Hennessy Sr, Chairman;Founder, MJH Life Sciences
September 25th 2020
ArticleHealth-System Edition

As we head into flu season, count on Directions in Health-System Pharmacy™ to continue to report on the latest developments on COVID-19.